MR Fingerprinting for Vestibular Schwannomas

Status Recruiting

Clinical Trial Summary

MR Fingerprinting (MRF) will be performed in patients who will be treated with Gamma Knife radio surgery for a vestibular schwannoma before the intervention. Fifty patients will be included with a vestibular schwannoma of minimum 1cm in size. During follow-up, response of the tumor to radiosurgery will be evaluated for each patient with MRI. The aim of the study is to find patterns of vestibular schwannomas in MRF data which correlate with the type of response to radio surgery, i.e. tumor control after radiosurgery, further tumor growth despite radiosurgery, cystic transformation after radiosurgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04851925
Study type	Observational
Source	Medical University of Vienna
Contact	Dorian Hirschmann, MD
Phone	+4314040025780
Email	dorian.hirschmann@meduniwien.ac.at
Status	Recruiting
Phase
Start date	February 24, 2021
Completion date	December 24, 2025

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04196933` - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma	N/A
Active, not recruiting	`NCT00973739` - Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors	Phase 2
Completed	`NCT04351373` - Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560	Phase 2
Active, not recruiting	`NCT01449604` - Stereotactic Radiation in Vestibular Schwannoma	Phase 3
Completed	`NCT01207687` - Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)	Phase 2
Not yet recruiting	`NCT05567341` - Remote Ischemic Preconditioning in Vestibular Schwannoma Surgery	N/A
Completed	`NCT02249572` - Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.	N/A
Terminated	`NCT05116878` - Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma	N/A
Suspended	`NCT03095248` - Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors	Phase 2
Recruiting	`NCT04801953` - Nimodipine in Vestibular Schwanommas	Phase 2
Recruiting	`NCT03745560` - Intraoperative EABR for Decision Making
Recruiting	`NCT04859335` - Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma	N/A
Recruiting	`NCT04128345` - Novel Multimodality Imaging for Navigation in Skull Base Surgery
Active, not recruiting	`NCT01199978` - Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma	Phase 2
Recruiting	`NCT04057976` - Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas	N/A
Completed	`NCT00863122` - Concentration and Activity of Lapatinib in Vestibular Schwannomas	Early Phase 1
Recruiting	`NCT04374305` - Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)	Phase 2
Recruiting	`NCT03079999` - Study of Aspirin in Patients With Vestibular Schwannoma	Phase 2
Recruiting	`NCT05786144` - Vestibular Schwannoma Organoids
Recruiting	`NCT03593577` - Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI